Literature DB >> 20660329

"Double-Hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression.

David Wu1, Brent L Wood, Russell Dorer, Jonathan R Fromm.   

Abstract

Lymphomas with 2 translocations involving c-MYC and BCL2 or BCL6 are a subset of biologically aggressive mature B-cell lymphomas now frequently categorized under the entity of B-cell lymphoma, unclassifiable, with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma. We identified a cohort of these lymphomas in our databases and retrospectively reviewed corresponding in-house flow cytometric data to determine whether a common immunophenotype might be present. Herein we report on our findings on 10 lymphomas, each with translocations involving c-MYC and BCL2 or BCL6 and show that these cases frequently showed a common immunophenotype that includes decreased expression of CD20. Because these lymphomas often show aggressive biologic behavior and poor clinical outcome, recognition of this relatively common immunophenotype may be useful for identifying cases for confirmatory cytogenetic studies, as often, flow cytometry provides the first assessment of these clinical specimens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660329     DOI: 10.1309/AJCP7YLDTJPLCE5F

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

Review 1.  Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?

Authors:  Deborah A Thomas; Susan O'Brien; Stefan Faderl; John T Manning; Jorge Romaguera; Luis Fayad; Fredrick Hagemeister; Jeffrey Medeiros; Jorge Cortes; Hagop Kantarjian
Journal:  Curr Hematol Malig Rep       Date:  2011-03       Impact factor: 3.952

Review 2.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

3.  Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL.

Authors:  L Smyth; P V Browne; E Conneally; C Flynn; P Hayden; M Jeffers; D O'Brien; F Quinn; J Kelly; M Perera; G M Crotty; M Leahy; B Hennessy; F Jackson; M Ryan; E Vandenberghe
Journal:  Ir J Med Sci       Date:  2015-04-07       Impact factor: 1.568

4.  Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.

Authors:  Chen Lossos; Yunpeng Liu; Kellie E Kolb; Amanda L Christie; Alexandria Van Scoyk; Sanjay M Prakadan; Kay Shigemori; Kristen E Stevenson; Sara Morrow; Olivia D Plana; Cameron Fraser; Kristen L Jones; Huiyun Liu; Christian P Pallasch; Rebecca Modiste; Quang-De Nguyen; Jeffrey W Craig; Elizabeth A Morgan; Francisco Vega; Jon C Aster; Kristopher A Sarosiek; Alex K Shalek; Michael T Hemann; David M Weinstock
Journal:  Cancer Discov       Date:  2019-04-30       Impact factor: 39.397

5.  Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system.

Authors:  Paul McGowan; Nicole Nelles; Jana Wimmer; Dawn Williams; Jianguo Wen; Marilyn Li; April Ewton; Choladda Curry; Youli Zu; Andrea Sheehan; Chung-Che Jeff Chang
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

6.  Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.

Authors:  Laura Moench; Zohar Sachs; Garth Aasen; Michelle Dolan; Vanessa Dayton; Elizabeth L Courville
Journal:  Leuk Lymphoma       Date:  2016-02-18

7.  Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies.

Authors:  Ilya Leskov; Christian P Pallasch; Adam Drake; Bettina P Iliopoulou; Amanda Souza; Ching-Hung Shen; Carmen D Schweighofer; Lynne Abruzzo; Lukas P Frenzel; Clemens M Wendtner; Michael T Hemann; Jianzhu Chen
Journal:  Oncogene       Date:  2012-04-09       Impact factor: 9.867

Review 8.  Aggressive B-cell lymphomas: how many categories do we need?

Authors:  Jonathan W Said
Journal:  Mod Pathol       Date:  2012-11-16       Impact factor: 7.842

9.  Orbital sporadic Burkitt lymphoma in an adult diabetic African American female and a review of adult orbital cases.

Authors:  John Carmody; Raghunath P Misra; Marlyn P Langford; William A Byrd; Lauren Ditta; Bryan Vekovius; Donald E Texada
Journal:  Clin Ophthalmol       Date:  2011-04-20

10.  Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.

Authors:  Lan V Pham; Gary Lu; Archito T Tamayo; Juan Chen; Pramoda Challagundla; Jeffrey L Jorgensen; L Jeffrey Medeiros; Richard J Ford
Journal:  J Hematol Oncol       Date:  2015-10-29       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.